{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:14:34Z","timestamp":1784139274563,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41391-025-00961-0","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T01:22:40Z","timestamp":1743124960000},"page":"927-937","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Does biodegradable peri-rectal spacer mitigate treatment toxicities in radiation therapy for localised prostate cancer\u2014a systematic review and meta-analysis"],"prefix":"10.1038","volume":"28","author":[{"given":"Chris Ho-Ming","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Ching-Ho","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Ka-Wai","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9956-1558","authenticated-orcid":false,"given":"Steffi Kar-Kei","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9361-2342","authenticated-orcid":false,"given":"Jeremy Yuen-Chun","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"961_CR1","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","volume":"70","author":"MJ Zelefsky","year":"2008","unstructured":"Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:1124\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","volume":"92","author":"N Mariados","year":"2015","unstructured":"Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image-guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015;92:971\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR3","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ijrobp.2016.12.024","volume":"97","author":"DA Hamstra","year":"2017","unstructured":"Hamstra DA, Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, et al. Continued benefit to rectal separation for prostate radiation therapy: final results of a phase III trial. Int J Radiat Oncol Biol Phys. 2017;97:976\u201385.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.urology.2017.11.016","volume":"115","author":"LI Karsh","year":"2018","unstructured":"Karsh LI, Gross ET, Pieczonka CM, Aliotta PJ, Skomra CJ, Ponsky LE, et al. Absorbable hydrogel spacer use in prostate radiotherapy: a comprehensive review of phase 3 clinical trial published data. Urology. 2018;115:39\u201344.","journal-title":"Urology"},{"key":"961_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijrobp.2012.12.019","volume":"87","author":"DY Song","year":"2013","unstructured":"Song DY, Herfarth KK, Uhl M, Eble MJ, Pinkawa M, van Triest B, et al. A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes. Int J Radiat Oncol Biol Phys. 2013;87:81\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1239104","volume":"13","author":"ZA Seymour","year":"2023","unstructured":"Seymour ZA, Pinkawa M, Daignault-Newton S, Bosch W, Michalski JM, Gay H, et al. A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life. Front Oncol. 2023;13:1239104.","journal-title":"Front Oncol"},{"key":"961_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamaoncol.2022.7592","volume":"9","author":"NF Mariados","year":"2023","unstructured":"Mariados NF, Orio PF, Schiffman Z, Van TJ, Engelman A, Nurani R, et al. Hyaluronic acid spacer for hypofractionated prostate radiation therapy: a randomized clinical trial. JAMA Oncol. 2023;9:511\u20138.","journal-title":"JAMA Oncol"},{"key":"961_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-021-01834-1","volume":"16","author":"M Ogita","year":"2021","unstructured":"Ogita M, Yamashita H, Nozawa Y, Ozaki S, Sawayanagi S, Ohta T, et al. Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison. Radiat Oncol. 2021;16:107.","journal-title":"Radiat Oncol"},{"key":"961_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00066-016-1040-6","volume":"193","author":"M Pinkawa","year":"2017","unstructured":"Pinkawa M, Berneking V, K\u00f6nig L, Frank D, Bretgeld M, Eble MJ. Hydrogel injection reduces rectal toxicity after radiotherapy for localized prostate cancer. Strahlenther Onkol. 2017;193:22\u20138.","journal-title":"Strahlenther Onkol"},{"key":"961_CR10","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1016\/j.clon.2016.05.005","volume":"28","author":"D Whalley","year":"2016","unstructured":"Whalley D, Hruby G, Alfieri F, Kneebone A, Eade T. SpaceOAR hydrogel in dose-escalated prostate cancer radiotherapy: rectal dosimetry and late toxicity. Clin Oncol. 2016;28:e148\u2013e54.","journal-title":"Clin Oncol"},{"key":"961_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.brachy.2023.07.005","volume":"22","author":"MK Abdelhakiem","year":"2023","unstructured":"Abdelhakiem MK, Keller A, Bajpai RR, Smith RP, Beriwal S, Benoit R. Cs-131 prostate brachytherapy boost and effect of hydrogel rectal spacer on long-term patient-reported rectal bleeding and bowel quality of life. Brachytherapy. 2023;22:808\u201321.","journal-title":"Brachytherapy"},{"key":"961_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.prnil.2022.06.003","volume":"10","author":"T Taniguchi","year":"2022","unstructured":"Taniguchi T, Iinuma K, Nakano M, Kawase M, Takeuchi S, Kato D, et al. Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR system. Prostate Int. 2022;10:207\u201312.","journal-title":"Prostate Int"},{"key":"961_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.853246","volume":"12","author":"P Kundu","year":"2022","unstructured":"Kundu P, Lin EY, Yoon SM, Parikh NR, Ruan D, Kishan AU, et al. Rectal radiation dose and clinical outcomes in prostate cancer patients treated with stereotactic body radiation therapy with and without hydrogel. Front Oncol. 2022;12:853246.","journal-title":"Front Oncol"},{"key":"961_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bju.15572","volume":"129","author":"A Teyateeti","year":"2022","unstructured":"Teyateeti A, Grossman C, Kollmeier MA, Fiasconaro M, Hopkins M, McBride S, et al. Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity. BJU Int. 2022;129:337\u201344.","journal-title":"BJU Int"},{"key":"961_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00345-022-03953-0","volume":"40","author":"MN Alshak","year":"2022","unstructured":"Alshak MN, Eidelberg A, Diaz SM, Stoddard MD, Formenti S, Nagar H, et al. Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a rectal hydrogel spacer. World J Urol. 2022;40:1143\u201350.","journal-title":"World J Urol"},{"key":"961_CR16","first-page":"266","volume":"65","author":"Y Lin","year":"2021","unstructured":"Lin Y, Ong W, Tacey M, Bolton D, Tan A, Chan Y, et al. Effect of hydrogel and hyaluronic acid rectal spacer on rectal dosimetry and toxicity in low-dose-rate prostate brachytherapy. J Med Imaging Radiat Oncol. 2021;65:266.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"961_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s10147-020-01855-y","volume":"26","author":"H Kobayashi","year":"2021","unstructured":"Kobayashi H, Eriguchi T, Tanaka T, Ogata T, Ishida M, Nakajima Y, et al. Distribution analysis of hydrogel spacer and evaluation of rectal dose reduction in Japanese prostate cancer patients undergoing stereotactic body radiation therapy. Int J Clin Oncol. 2021;26:736\u201343.","journal-title":"Int J Clin Oncol"},{"key":"961_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.adro.2019.08.007","volume":"5","author":"A Navaratnam","year":"2020","unstructured":"Navaratnam A, Cumsky J, Abdul-Muhsin H, Gagneur J, Shen J, Kosiorek H, et al. Assessment of polyethylene glycol hydrogel spacer and its effect on rectal radiation dose in prostate cancer patients receiving proton beam radiation therapy. Adv Radiat Oncol. 2020;5:92\u2013100.","journal-title":"Adv Radiat Oncol"},{"key":"961_CR19","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/1754-9485.12945","volume":"63","author":"BL te Velde","year":"2019","unstructured":"te Velde BL, Westhuyzen J, Awad N, Wood M, Shakespeare TP. Late toxicities of prostate cancer radiotherapy with and without hydrogel SpaceAOR insertion. J Med Imaging Radiat Oncol. 2019;63:836\u201341.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"961_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5114\/jcb.2019.82836","volume":"11","author":"M Chao","year":"2019","unstructured":"Chao M, Ow D, Ho H, Chan Y, Joon DL, Spencer S, et al. Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel space. J Contemp Brachytherapy. 2019;11:8\u201313.","journal-title":"J Contemp Brachytherapy"},{"key":"961_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.brachy.2017.11.006","volume":"17","author":"AS Taggar","year":"2018","unstructured":"Taggar AS, Charas T, Cohen GN, Boonyawan K, Kollmeier M, McBride S, et al. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103. Brachytherapy. 2018;17:251\u20138.","journal-title":"Brachytherapy"},{"key":"961_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024;86:148\u201363.","journal-title":"Eur Urol"},{"key":"961_CR23","doi-asserted-by":"publisher","first-page":"e208221","DOI":"10.1001\/jamanetworkopen.2020.8221","volume":"3","author":"LE Miller","year":"2020","unstructured":"Miller LE, Efstathiou JA, Bhattacharyya SK, Payne HA, Woodward E, Pinkawa M. Association of the placement of a perirectal hydrogel spacer with the clinical outcomes of men receiving radiotherapy for prostate cancer: a systematic review and meta-analysis. JAMA Netw Open. 2020;3:e208221.","journal-title":"JAMA Netw Open"},{"key":"961_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/iju.15140","volume":"30","author":"H Yamaguchi","year":"2023","unstructured":"Yamaguchi H, Kato T, Ishikawa Y, Takemasa K, Narita Y, Takagawa Y, et al. Safety of hydrogel spacers for rectal wall protection in patients with prostate cancer: a retrospective analysis of 200 consecutive cases. Int J Urol. 2023;30:401\u20137.","journal-title":"Int J Urol"},{"key":"961_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.urpr.2015.04.002","volume":"3","author":"CM Pieczonka","year":"2016","unstructured":"Pieczonka CM, Mariados N, Sylvester JE, Karsh LI, Hudes RS, Beyer DC, et al. Hydrogel spacer application technique, patient tolerance and impact on prostate intensity modulated radiation therapy: results from a prospective, multicenter, pivotal randomized controlled trial. Urol Pract. 2016;3:141\u20136.","journal-title":"Urol Pract"},{"key":"961_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","volume":"112","author":"A Freites-Martinez","year":"2021","unstructured":"Freites-Martinez A, Santana N, Arias-Santiago S, Viera A. Using the common terminology criteria for adverse events (CTCAE - version 5.0) to evaluate the severity of adverse events of anticancer therapies. Actas Dermosifiliogr. 2021;112:90\u20132.","journal-title":"Actas Dermosifiliogr"},{"key":"961_CR27","doi-asserted-by":"publisher","first-page":"e28111","DOI":"10.1097\/MD.0000000000028111","volume":"100","author":"HA Payne","year":"2021","unstructured":"Payne HA, Pinkawa M, Peedell C, Bhattacharyya SK, Woodward E, Miller LE. SpaceOAR hydrogel spacer injection prior to stereotactic body radiation therapy for men with localized prostate cancer: a systematic review. Medecine. 2021;100:e28111.","journal-title":"Medecine"},{"key":"961_CR28","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/1754-9485.13179","volume":"65","author":"M Babar","year":"2021","unstructured":"Babar M, Katz A, Ciatto M. Dosimetric and clinical outcomes of SpaceOAR in men undergoing external beam radiation therapy for localized prostate cancer: a systematic review. J Med Imaging Radiat Oncol. 2021;65:384\u201397.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"961_CR29","doi-asserted-by":"crossref","unstructured":"Armstrong N, Bahl A, Pinkawa M, Ryder S, Ahmadu C, Ross J, et al. SpaceOAR hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. a systematic review. Urology. 2021:156:e74\u201385.","DOI":"10.1016\/j.urology.2021.05.013"},{"key":"961_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brachy.2019.08.009","volume":"19","author":"M Afkhami Ardekani","year":"2020","unstructured":"Afkhami Ardekani M, Ghaffari H. Optimization of prostate brachytherapy techniques with polyethylene glycol-based hydrogel spacers: a systematic review. Brachytherapy. 2020;19:13\u201323.","journal-title":"Brachytherapy"},{"key":"961_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1470-2045(15)00567-7","volume":"17","author":"S Aluwini","year":"2016","unstructured":"Aluwini S, Pos F, Schimmel E, Krol S, van der Toorn PP, de Jager H, et al. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial. Lancet Oncol. 2016;17:464\u201374.","journal-title":"Lancet Oncol"},{"key":"961_CR32","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","volume":"17","author":"D Dearnaley","year":"2016","unstructured":"Dearnaley D, Syndikus I, Mossop H, Khoo V, Birtle A, Bloomfield D, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17:1047\u201360.","journal-title":"Lancet Oncol"},{"key":"961_CR33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijrobp.2017.05.035","volume":"99","author":"M Pinkawa","year":"2017","unstructured":"Pinkawa M, Berneking V, Schlenter M, Krenkel B, Eble MJ. Quality of life after radiation therapy for prostate cancer with a hydrogel spacer: 5-year results. Int J Radiat Oncol Biol Phys. 2017;99:374\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR34","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.3390\/curroncol28040257","volume":"28","author":"MA Gomez-Aparicio","year":"2021","unstructured":"Gomez-Aparicio MA, Valero J, Caballero B, Garcia R, Hernando-Requejo O, Montero A, et al. Extreme hypofractionation with SBRT in localized prostate cancer. Curr Oncol. 2021;28:2933\u201349.","journal-title":"Curr Oncol"},{"key":"961_CR35","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ijrobp.2017.07.021","volume":"99","author":"NR Datta","year":"2017","unstructured":"Datta NR, Stutz E, Rogers S, Bodis S. Conventional versus hypofractionated radiation therapy for localized or locally advanced prostate cancer: a systematic review and meta-analysis along with therapeutic implications. Int J Radiat Oncol Biol Phys. 2017;99:573\u201389.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR36","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.clon.2021.12.006","volume":"34","author":"MT Corkum","year":"2022","unstructured":"Corkum MT, Achard V, Morton G, Zilli T. Ultrahypofractionated radiotherapy for localised prostate cancer: how far can we go? Clin Oncol. 2022;34:340\u20139.","journal-title":"Clin Oncol"},{"key":"961_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-01622-3","volume":"15","author":"F Cuccia","year":"2020","unstructured":"Cuccia F, Mazzola R, Nicosia L, Figlia V, Giaj-Levra N, Ricchetti F, et al. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy. Radiat Oncol. 2020;15:178.","journal-title":"Radiat Oncol"},{"key":"961_CR38","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210521","volume":"94","author":"R Mazzola","year":"2021","unstructured":"Mazzola R, Sicignano G, Cuccia F, Vitale C, Rigo M, Giaj-Levra N, et al. Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer. Br J Radiol. 2021;94:20210521.","journal-title":"Br J Radiol"},{"key":"961_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2021.100647","volume":"6","author":"J Applewhite","year":"2021","unstructured":"Applewhite J, Barker J Jr, Vestal JC. Successful use of absorbable hydrogel rectal spacers (SpaceOAR) before salvage radiation therapy after previous prostate cryotherapy. Adv Radiat Oncol. 2021;6:100647.","journal-title":"Adv Radiat Oncol"},{"key":"961_CR40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00066-014-0769-z","volume":"191","author":"M Pinkawa","year":"2015","unstructured":"Pinkawa M, Schubert C, Escobar-Corral N, Holy R, Eble MJ. Application of a hydrogel spacer for postoperative salvage radiotherapy of prostate cancer. Strahlenther Onkol. 2015;191:375\u20139.","journal-title":"Strahlenther Onkol"},{"key":"961_CR41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5114\/jcb.2023.126051","volume":"15","author":"T Opbroek","year":"2023","unstructured":"Opbroek T, Cobussen A, Van Limbergen EJ, Vanneste BGL. Focal salvage high-dose-rate brachytherapy with implantable rectum spacer for locally recurrent prostate cancer after initial low-dose-rate with grade 3 rectal toxicity. J Contemp Brachytherapy. 2023;15:154\u20138.","journal-title":"J Contemp Brachytherapy"},{"key":"961_CR42","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/S0360-3016(01)01694-7","volume":"51","author":"MJ McDonough","year":"2001","unstructured":"McDonough MJ, Feldmeier JJ, Parsai I, Dobelbower RR Jr, Selman SH. Salvage external beam radiotherapy for clinical failure after cryosurgery for prostate cancer. Int J Radiat Oncol Biol Phys. 2001;51:624\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"961_CR43","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11934-005-0007-4","volume":"6","author":"JC Vestal","year":"2005","unstructured":"Vestal JC. Critical review of the efficacy and safety of cryotherapy of the prostate. Curr Urol Rep. 2005;6:190\u20133.","journal-title":"Curr Urol Rep."},{"key":"961_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brachy.2012.03.005","volume":"12","author":"PL Nguyen","year":"2013","unstructured":"Nguyen PL, Devlin PM, Beard CJ, Orio PF 3rd, O\u2019Leary MP, Wolfsberger LD, et al. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature. Brachytherapy. 2013;12:77\u201383.","journal-title":"Brachytherapy"},{"key":"961_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00345-024-04784-x","volume":"42","author":"DMC Poon","year":"2024","unstructured":"Poon DMC, Yuan J, Wong OL, Yang B, Tse MY, Lau KK, et al. One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer. World J Urol. 2024;42:97.","journal-title":"World J Urol"},{"key":"961_CR46","doi-asserted-by":"crossref","unstructured":"Fredman E, Moore A, Icht O, Tschernichovsky R, Shemesh D, Bragilovski D, et al. Acute toxicity and early prostate specific antigen response after two-fraction stereotactic radiation therapy for localized prostate cancer using peri-rectal spacing - initial report of the SABR-dual trial. Int J Radiat Oncol Biol Phys. 2024;120:1404\u20139.","DOI":"10.1016\/j.ijrobp.2024.06.038"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00961-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00961-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00961-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:07:05Z","timestamp":1764047225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00961-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["961"],"URL":"https:\/\/doi.org\/10.1038\/s41391-025-00961-0","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"8 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval is waived for the study did not involve the use data from individual patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}